S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.83%) $83.15
Gas
(1.35%) $1.949
Gold
(-0.16%) $2 343.50
Silver
(0.18%) $27.59
Platinum
(0.80%) $929.50
USD/EUR
(-0.30%) $0.932
USD/NOK
(-0.44%) $10.98
USD/GBP
(-0.40%) $0.797
USD/RUB
(0.25%) $92.11

リアルタイムの更新: CSL Limited [CSLLY]

取引所: OTC セクター: Healthcare 産業: Biotechnology
最終更新日時27 4月 2024 @ 04:56

-0.62% $ 89.60

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 04:56):

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
本日の出来高 26 287.00
平均出来高 32 709.00
時価総額 86.60B
Last Dividend $0.645 ( 2023-09-08 )
Next Dividend $0 ( N/A )
P/E 35.28
ATR14 $0.210 (0.23%)

ボリューム 相関

長: 0.05 (neutral)
短: 0.82 (strong)
Signal:(51.123) Same movement expected

CSL Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

CSL Limited 相関 - 通貨/商品

The country flag -0.34
( neutral )
The country flag -0.19
( neutral )
The country flag 0.13
( neutral )
The country flag -0.36
( neutral )
The country flag 0.05
( neutral )
The country flag -0.04
( neutral )

CSL Limited 財務諸表

Annual 2023
収益: $13.17B
総利益: $6.71B (50.92 %)
EPS: $2.27
FY 2023
収益: $13.17B
総利益: $6.71B (50.92 %)
EPS: $2.27
FY 2022
収益: $10.49B
総利益: $5.66B (53.97 %)
EPS: $2.40
FY 2021
収益: $10.27B
総利益: $5.80B (56.49 %)
EPS: $2.62

Financial Reports:

No articles found.

CSL Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.590
(N/A)
$0
(N/A)
$0.535
(N/A)
$0
(N/A)
$0.645
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Limited Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.66 - Stable (13.14%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.158 2010-03-10
Last Dividend $0.645 2023-09-08
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 28 --
Total Paid Out $10.42 --
Avg. Dividend % Per Year 0.00% --
Score 4.02 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.66
Div. Directional Score 9.13 --
Next Divdend (Est)
(2024-07-01)
$0.671 Estimate 7.55 %
Dividend Stability
0.30 Poor
Dividend Score
4.02
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
NODB Ex Dividend Junior 2023-10-17 Quarterly 0 0.00%
CUYTY Ex Dividend Junior 2023-09-29 Annually 0 0.00%
THUPY Ex Dividend Knight 2023-10-04 Semi-Annually 0 0.00%
IESFY Ex Dividend Knight 2023-05-16 Semi-Annually 0 0.00%
BDNNY Ex Dividend Junior 2023-05-09 Semi-Annually 0 0.00%
PNGAY Ex Dividend Knight 2023-09-08 Semi-Annually 0 0.00%
EGIEY Ex Dividend Knight 2023-08-31 Quarterly 0 0.00%
UEPEO Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
KGFHY Ex Dividend Knight 2023-10-12 Annually 0 0.00%
BZLFY Ex Dividend Knight 2023-11-16 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1771.5006.459.68[0 - 0.5]
returnOnAssetsTTM0.1181.2006.067.27[0 - 0.3]
returnOnEquityTTM0.2121.5008.7610.00[0.1 - 1]
payoutRatioTTM0.258-1.0007.42-7.42[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM9.551.0007.587.58[3 - 30]
operatingCashFlowPerShareTTM4.172.008.6110.00[0 - 30]
freeCashFlowPerShareTTM2.002.009.0010.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4981.0005.045.04[0.2 - 0.8]
operatingProfitMarginTTM0.2501.0007.017.01[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3831.0008.998.99[0.2 - 2]
assetTurnoverTTM0.6660.8008.897.11[0.5 - 2]
Total Score12.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM19.631.0008.120[1 - 100]
returnOnEquityTTM0.2122.509.2010.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.002.009.3310.00[0 - 30]
dividendYielPercentageTTM1.3841.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.172.008.6110.00[0 - 30]
payoutRatioTTM0.2581.5007.42-7.42[0 - 1]
pegRatioTTM-3.621.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1621.0008.450[0.1 - 0.5]
Total Score5.66

CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。